The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liu, Daren ^a   Trojanowicz, Bogusz ^b   Ye, Longyun ^a   Li, Chao ^a   Zhang, Luqing ^a   Li, Xiaowen ^a   Li, Guogang ^a   Zheng, Yixiong ^a   Chen, Li ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD97 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; STOMACH CARCINOMA;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN ISOFORMS; RNA INTERFERENCE; STOMACH NEOPLASMS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863104160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039989     Document Type: Article

References (38)

1. van Lier RA, Eichler W, Hamann J, (1996) Sevenspan transmembrane molecules: novel receptors involved in leukocyte adhesion. Immunol Lett 54: 185-187.
2. Hamann J, Hartmann E, van Lier RA, (1996) Structure of the human CD97 gene: exon shuffling has generated a new type of seven-span transmembrane molecule related to the secretin receptor superfamily. Genomics 32: 144-147.
3. McKnight AJ, Gordon S, (1996) EGF-TM7: a novel subfamily of seven-transmembrane-region leukocyte cell-surface molecules. Immunol Today 17: 283-287.
4. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, et al. (1996) CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157: 5438-5447.
5. Spendlove I, Ramage JM, Bradley R, Harris C, Durrant LG, (2006) Complement decay accelerating factor (DAF)/CD55 in cancer. Cancer Immunol Immunother 55: 987-995.
6. Mikesch JH, Schier K, Roetger A, Simon R, Buerger H, et al. (2006) The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy. Cell Oncol 28: 223-232.
7. Martens GJ, (1992) Molecular biology of G-protein-coupled receptors. Prog Brain Res 92: 201-214.
8. Eichler W, Aust G, Hamann D, (1994) Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2). Scand J Immunol 39: 111-115.
9. Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, et al. (2002) Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol 161: 1657-1667.
10. Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, et al. (1999) Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab 84: 1104-1109.
11. Jaspars LH, Vos W, Aust G, Van Lier RA, Hamann J, (2001) Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 57: 325-331.
12. Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, et al. (1997) CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798-1806.
13. Inoue T, Yamakawa M, Takahashi T, (2002) Expression of complement regulating factors in gastric cancer cells. Mol Pathol 55: 193-199.
14. Liu Y, Chen L, Peng SY, Chen ZX, Hoang-Vu C, (2005) Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. J Zhejiang Univ Sci B 6: 913-918.
15. Aust G, Steinert M, Schütz A, Boltze C, Wahlbuhl M, et al. (2002) CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas. Am J Clin Pathol 118: 699-707.
16. Liu Y, Chen L, Peng S, Chen Z, Gimm O, et al. (2005) The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas. Oncol Rep 14: 1413-1420.
17. Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, et al. (2006) Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion. Am J Pathol 169: 1802-1811.
18. Hensel F, Hermann R, Brändlein S, Krenn V, Schmausser B, et al. (2001) Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis. Lab Invest 81: 1553-1563.
19. Liu D, Trojanowicz B, Radestock Y, Fu T, Hammje K, et al. (2010) Role of CD97 isoforms in gastric carcinoma. Int J Oncol 36: 1401-1408.
20. Park KJ, Choi HJ, Roh MS, Kwon HC, Kim C, (2005) Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48: 1597-1602.
21. Nakanishi Y, Ochiai A, Kato H, Tachimori Y, Igaki H, et al. (2001) Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer 91: 1114-1120.
22. Weiss L, Mayhew E, Rapp DG, Holmes JC, (1982) Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer 45: 44-53.
23. Hiratsuka S, Watanabe A, Aburatani H, Maru Y, (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375.
24. Zöller M, (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9: 40-55.
25. Kaplan RN, Rafii S, Lyden D, (2006) Preparing the 'soil': the premetastatic niche. Cancer Res 66: 11089-11093.
26. Li L, Neaves WB, (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553-4557.
27. Yin T, Li L, (2006) The stem cell niches in bone. J Clin Invest 116: 1195-1201.
28. Zhang J, Li L, (2008) Stem cell niche: microenvironment and beyond. J Biol Chem 283: 9499-9503.
29. Folkman J, (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18.
30. Weigelt B, Bissell MJ, (2008) Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 18: 311-321.
31. Joyce JA, Hanahan D, (2004) Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3: 1516-1619.
32. Psaila B, Lyden D, (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9: 285-293.
33. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
34. Zöller M, (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267.
35. Nie D, (2011) Cancer stem cell and niche. Front Biosci (Schol Ed) 2: 184-193.
36. Iwasaki H, Suda T, (2009) Cancer stem cells and their niche. Cancer Sci 100: 1166-1172.
37. Jung T, Castellana D, Klingbeil P, Cuesta Hernández I, Vitacolonna M, et al. (2009) CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11: 1093-1105.
38. Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC, (2012) Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness. J Neurosurg 116: 843-853.